Arcus Biosciences, Inc. (RCUS)
25.38
+0.30
(+1.22%)
USD |
NYSE |
Dec 10, 16:00
25.38
0.00 (0.00%)
After-Hours: 16:16
Arcus Biosciences Total Liabilities (Quarterly): 538.00M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Actinium Pharmaceuticals, Inc. | 42.37M |
| Apyx Medical Corp. | 51.28M |
| Gilead Sciences, Inc. | 37.08B |
| Merck & Co., Inc. | 77.64B |
| Karyopharm Therapeutics, Inc. | 365.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 974.00M |
| Shareholders Equity (Quarterly) | 436.00M |
| Debt to Equity Ratio | 0.2546 |
| Current Ratio | 3.647 |
| Net Debt Paydown Yield | -1.37% |